BOSTON – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone, muscle, red blood cells and vasculature, has executed a new 19,711-square-foot lease for biotechnology laboratory space at 12 Emily Street in Cambridge, Mass. 

Acceleron Pharma currently occupies a total of 75,000 square feet at 128 & 149 Sidney Streets, and will expand its Cambridge presence to 12 Emily Street in June 2009. 

Colliers Meredith & Grew’s Joe Flaherty and Tucker Hansen represented Acceleron Pharma in the transaction.  The landlord, the Massachusetts Institute of Technology, represented itself, with John McQuaid, Senior Real Estate Officer, and Patrick Rowe, Senior Investment Associate, handling the negotiations for the Institute. Specifics of the lease transaction were not disclosed.

12 Emily Street is a two-story, 30,000-square-foot flexible office/research and development building. Located two blocks from University Park at M.I.T. and in close proximity to the M.I.T. campus, 12 Emily Street is ideally situated within Cambridge’s thriving biotechnology community.

“The addition of the 12 Emily Street facility provides additional wet laboratory and administrative office space adjacent to our existing other two facilities and will help support our rapid growth,” said Nancy Sullivan, Senior Director of Operations for Acceleron.